Ads Top

The Devastating Charge Sheet Against Pfizer

 


We’ve extracted the main points from the Kansas City Attorney General’s legal report on the case against Pfizer that we first mentioned in ‘Due Process‘ — all quotes are taken verbatim.

 

This is a lengthy post, and we’d recommend having an anger management strategy to hand while reading. If you are making a comment, use the numbering to highlight which points you are referring to, and do let us know if we’ve missed anything. 

 

  1. Pfizer misled the public.
  • In May 2021, Pfizer advertised to Kansans on Facebook about its “life-saving vaccines” and its “cures”. Upon information and belief, Pfizer intended for Kansans to think of its COVID-19 vaccine when it discussed “life-saving vaccines” and “cures”. Pfizer ran three different ads between May 4th 2021 and June 1st 2021 that received 165,000 to 190,000 impressions.
  • Pfizer received emergency use authorisation for its COVID-19 vaccine in individuals 16 years of age and older on December 11th 2020.
  • Pfizer received FDA approval on August 23rd 2021. From 2021 to 2023, Pfizer received emergency use authorisations in children from six months to 15 years of age.
  1. Pfizer used confidentiality agreements to conceal critical data relating to the safety and effectiveness of its COVID-19 vaccine.
  • Pfizer effectively had a veto over the federal Government’s communications.
  1. Pfizer used its confidentiality agreements with the U.S. Government and others to conceal, suppress and omit material facts relating to Pfizer’s COVID-19 vaccine, including the safety and efficacy of the vaccine.
  2. Pfizer used an extended study timeline to conceal critical data – the study was repeatedly delayed.
  • Pfizer planned to provide researchers with access to patient-level data and full clinical study reports 24 months after study completion. Protocol C4591001
  • Pfizer estimated that it would complete the study by January 27th 2023, but that estimated date fell back to February 2024 because of a late vaccination of a single study participant (out of 44,000 participants).
  • Pfizer’s control of the data allowed the company to selectively publish results for which the underlying data could not be independently evaluated.
  1. Pfizer says it will make data from vaccine trials approved in the U.S. available 18 months after the primary study completion date. Pfizer, Data Access Requests.
  • Upon information and belief, Pfizer has still not made its complete study data available to researchers.

 

Read More Here: DailySceptic

Powered by Blogger.